Split History
ETFs Holding IBIO »    IBIO Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
iBio is a preclinical stage biotechnology company that utilizes its artificial intelligence (AI) for the development of precision antibodies. Co.'s technology stack of epitope-steering AI-engine allows it to target related regions of proteins with unprecedented precision enabling the creation of antibodies specific to relevant regions within large target proteins. Co.'s machine learning based antibody-optimizing StableHu™ technology, when coupled with its mammalian display technology, has been shown to support the Lead Optimization process and potentially reduces downstream risks. Co. also developed the EngageTx™ platform, which provides a CD3 T-cell engager antibody panel. According to our IBIO split history records, iBio has had 3 splits.
IBIO split history picture
iBio (IBIO) has 3 splits in our IBIO split history database. The first split for IBIO took place on June 11, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of IBIO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. IBIO's second split took place on October 10, 2022. This was a 1 for 25 reverse split, meaning for each 25 shares of IBIO owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 4 share position following the split. IBIO's third split took place on November 29, 2023. This was a 1 for 20 reverse split, meaning for each 20 shares of IBIO owned pre-split, the shareholder now owned 1 share. For example, a 4 share position pre-split, became a 0.2 share position following the split.

When a company such as iBio conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the IBIO split history from start to finish, an original position size of 1000 shares would have turned into 0.2 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into iBio shares, starting with a $10,000 purchase of IBIO, presented on a split-history-adjusted basis factoring in the complete IBIO split history. IBIO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/25/2014
End date: 04/23/2024
Start price/share: $2,350.00
End price/share: $1.90
Dividends collected/share: $0.00
Total return: -99.92%
Average Annual Total Return: -50.93%
Starting investment: $10,000.00
Ending investment: $8.08
Years: 10.00
Date Ratio
06/11/20181 for 10
10/10/20221 for 25
11/29/20231 for 20
IBIO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ICAD Split History
ICCC Split History
ICLR Split History
ICUI Split History
IDRA Split History
IDXG Split History
IDXX Split History
IGC Split History
ILMN Split History
IMMY Split History

Email EnvelopeFree IBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Applied DNA Sciences, Inc. (APDN)
Cidara Therapeutics, Inc. (CDTX)
Smart for Life, Inc. (SMFL)
Windtree Therapeutics, Inc. (WINT)
Golden Sun Health Technology Group Limited (GSUN)
Zapp Electric Vehicles Group Limited (ZAPP)
Beneficient (BENF)
MySize, Inc. (MYSZ)
Gorilla Technology Group Inc. (GRRR)
Sunshine Biopharma, Inc. (SBFM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

IBIO Insider Buying

IBIO Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.